Stock SYNTA PHARMACEUTICALS CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Synta Pharmaceuticals Corp. Nasdaq

Equities

US87162T2069

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Synta Pharmaceuticals Corp.
11/06 Transcript : Madrigal Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:40 AM
06/06 Madrigal Pharmaceuticals Reports Positive Results in New Analysis of Phase 3 Trial of NASH Drug Rezdiffra MT

Chart calendar Synta Pharmaceuticals Corp.

790b7f2f9c98b86d8bde.82AlXO36dNkEb7etlJklVfoUtrZ_etVdeFK0FmvCaqw.gVFUcbmJJbdbF_2ZrMsRFootg9I4KJoYMgTWciGnR-OpDEg2pbEmn14Ogw~7a1b8132ba12f91d2ca329a347e16de0

Upcoming events on Synta Pharmaceuticals Corp.

06/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
26/02/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Synta Pharmaceuticals Corp.

25/06/2024 Annual General Meeting
11/06/2024 06:10 pm Goldman Sachs Global Healthcare Conference
07/05/2024 05:30 pm Q1 2024 Earnings Call
07/05/2024 04:30 pm Q1 2024 Earnings Release
15/03/2024 02:45 am Rezdiffra™ (resmetirom) Accelerated Approval Call
28/02/2024 05:30 pm Q4 2023 Earnings Release
11/01/2024 06:00 am JPMorgan Healthcare Conference
04/01/2024 NASH TAG Conference - Abstract No:27
04/01/2024 NASH TAG Conference - Abstract No:26
04/01/2024 NASH TAG Conference - Abstract No:25
04/01/2024 NASH TAG Conference - Abstract No:21
04/01/2024 NASH TAG Conference - Abstract No:41
30/11/2023 11:30 pm Piper Sandler Healthcare Conference
30/11/2023 01:30 am Evercore ISI HealthCONx Conference
09/11/2023 03:30 am UBS BioPharma Conference
06/11/2023 06:30 pm Q3 2023 Earnings Release
08/08/2023 05:30 pm Q2 2023 Earnings Release
24/06/2023 10:00 pm European Association for the Study of the Liver Congress
15/06/2023 06:30 pm Annual General Meeting
13/06/2023 09:50 pm Goldman Sachs Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
73,5

EBITDA
Million USD		Released
Forecast
Spread 		-94,9
-93,5
-1.44%		-206
-209
1.32%		-242
-244
0.7%		-293
-291
-0.77%		-380
-379
-0.29%
-610

EBIT
Million USD		Released
Forecast
Spread 		-95,0
-93,4
-1.66%		-207
-209
1.12%		-242
-244
0.66%		-294
-286
-2.59%		-380
-372
-2.42%
-612

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-83,9
-80,3
-4.57%		-202
-203
0.44%		-242
-242
0.26%		-295
-286
-3.35%		-374
-364
-2.75%
-598

Net income
Million USD		Released
Forecast
Spread 		-83,9
-80,3
-4.6%		-202
-203
0.44%		-242
-243
0.44%		-295
-287
-2.85%		-374
-365
-2.29%
-583

EPS
USD		Released
Forecast
Spread 		-5,45
-5,30
-2.74%		-13,1
-13,2
1.11%		-14,6
-14,7
0.21%		-17,2
-16,8
-2.69%		-20,0
-19,4
-2.78%
-27,7

Announcement Date26/02/2025/02/2124/02/2223/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
3,88


22,6


50,6


58,7


75,1

EBITDA
Million USD		Released
Forecast
Spread











-78,2
-88,5
11.6%








-152
-129
-17.96%
-138


-135


-124







EBIT
Million USD		Released
Forecast
Spread 		-57,6
-60,6
4.98%		-70,3
-63,8
-10.22%		-80,4
-73,0
-10.17%		-85,3
-77,9
-9.49%		-78,3
-86,7
9.6%		-86,5
-84,7
-2.03%		-98,5
-92,9
-6.02%		-117
-108
-8.27%		-152
-130
-16.89%
-163


-155


-132


-139


-127

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-57,5
-58,6
1.89%		-70,7
-65,3
-8.24%		-81,2
-71,3
-13.81%		-85,9
-76,6
-12.18%		-76,9
-87,8
12.46%		-85,8
-83,5
-2.71%		-98,7
-89,9
-9.86%		-112
-103
-8.51%		-148
-125
-18.22%
-162


-155


-132


-138


-127

Net income
Million USD		Released
Forecast
Spread 		-57,5
-60,0
4.06%		-70,7
-64,1
-10.29%		-81,2
-72,6
-11.89%		-85,9
-77,9
-10.23%		-76,9
-86,7
11.32%		-85,8
-82,6
-3.94%		-98,7
-90,1
-9.64%		-112
-105
-7.1%		-148
-123
-19.9%
-158


-150


-128


-138


-127

EPS
USD		Released
Forecast
Spread 		-3,36
-3,56
5.72%		-4,14
-3,68
-12.54%		-4,75
-4,14
-14.77%		-4,98
-4,50
-10.57%		-4,23
-4,99
15.15%		-4,69
-4,55
-3.12%		-5,34
-4,88
-9.4%		-5,68
-5,26
-7.88%		-7,38
-6,20
-19.09%
-7,65


-7,19


-6,08


-6,38


-5,84

Announcement Date09/05/2204/08/2203/11/2223/02/2309/05/2308/08/2306/11/2328/02/2407/05/24-----

Upcoming sector events for Synta Pharmaceuticals Corp.

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Synta Pharmaceuticals Corp.

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. MDGL Stock
  4. Stock
  5. Calendar Synta Pharmaceuticals Corp.